Exhaled Biomarkers in Idiopathic Pulmonary Fibrosis—A Six-Month Follow-up Study in Patients Treated with Pirfenidone

The mechanism of action of pirfenidone in idiopathic pulmonary fibrosis (IPF) has not been fully elucidated. To offer additional insight, we evaluated the change in the cytokine profile in exhaled breath condensate (EBC) following a six-month treatment with pirfenidone in patients with IPF. EBC conc...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaskiewicz, Kaja, Mycroft, Katarzyna, Maskey-Warzechowska, Marta, Paralusz, Karolina, Siemiez, Natalia, Nejman-Gryz, Patrycja, Barnas, Malgorzata, Krenke, Rafal, Gorska, Katarzyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465603/
https://www.ncbi.nlm.nih.gov/pubmed/32764328
http://dx.doi.org/10.3390/jcm9082523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465603/
https://www.ncbi.nlm.nih.gov/pubmed/32764328
http://dx.doi.org/10.3390/jcm9082523

Ejemplares similares